上证指数: 0000.00 0.00 00.00亿元 |
深圳成指: 0000.00 0.00 00.00亿元 |
沪深300: 0000.00 0.00 00.00亿元
| 鑫富药业(002019) 利润表 |
| 报告期 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 |
| 一、主营业务收入 | 295,993,704 | 155,456,620 | 764,741,629 | 547,920,713 | 334,292,243 |
| 折扣与折让 | 0 | 0 | 0 | 0 | 0 |
| 主营业务收入净额 | 295,993,704 | 155,456,620 | 764,741,629 | 547,920,713 | 334,292,243 |
| 主营业务成本 | 142,780,256 | 61,291,899 | 275,527,752 | 202,526,217 | 132,858,232 |
| 主营业务税金及附加 | 4,018,139 | 2,150,388 | 11,147,954 | 7,828,555 | 3,200,208 |
| 二、主营业务利润 | 149,195,309 | 92,014,333 | 478,065,923 | 337,565,940 | 198,233,804 |
| 其他业务利润 | 0 | 0 | 0 | 0 | 0 |
| 存货跌价损失 | 0 | 0 | 0 | 0 | 0 |
| 营业费用 | 16,574,489 | 10,205,287 | 43,140,633 | 34,691,778 | 23,117,237 |
| 管理费用 | 38,048,128 | 19,780,474 | 62,238,546 | 43,176,185 | 26,928,770 |
| 财务费用 | 7,277,022 | 5,795,709 | 20,205,557 | 13,954,271 | 9,912,861 |
| 三、营业利润 | 89,745,494 | 57,295,203 | 348,718,380 | 243,373,995 | 135,562,007 |
| 投资收益 | 871,770 | 516,054 | 1,539,620 | 1,156,152 | 0 |
| 补贴收入 | 0 | 0 | 0 | 0 | 0 |
| 营业外收入 | 2,905,611 | 610,333 | 1,756,967 | 1,883,883 | 1,208,740 |
| 营业外支出 | 1,687,259 | 627,108 | 3,279,331 | 2,049,443 | 1,294,298 |
| 以前年度损益调整 | 0 | 0 | 0 | 0 | 0 |
| 营业外收支净额 | 1,218,352 | -16,775 | -1,522,364 | -165,560 | -85,558 |
| 四、利润总额 | 91,835,615 | 57,794,482 | 348,735,636 | 244,364,586 | 135,476,448 |
| 所得税 | 23,124,549 | 15,677,698 | 108,546,300 | 84,257,368 | 47,446,381 |
| 财政返还 | 0 | 0 | 0 | 0 | 0 |
| 少数股东权益 | 0 | 0 | 0 | 0 | 0 |
| 购买日前净利润 | 0 | 0 | 0 | 0 | 0 |
| 未确认的投资损失 | 0 | 0 | 0 | 0 | 0 |
| 五、净利润 | 68,711,066 | 42,116,784 | 240,189,336 | 160,107,218 | 88,030,068 |
| 年初未分配利润 | 0 | 0 | 0 | 0 | 0 |
| 调整以前年度损益 | 0 | 0 | 0 | 0 | 0 |
| 盈余公积转入 | 0 | 0 | 0 | 0 | 0 |
| 住房周转金转入 | 0 | 0 | 0 | 0 | 0 |
| 其他转入 | 0 | 0 | 0 | 0 | 0 |
| 六、可分配利润 | 0 | 0 | 0 | 0 | 0 |
| 提取法定盈余公积 | 0 | 0 | 0 | 0 | 0 |
| 提取法定公益金 | 0 | 0 | 0 | 0 | 0 |
| 职工奖金福利 | 0 | 0 | 0 | 0 | 0 |
| 提取储备基金 | 0 | 0 | 0 | 0 | 0 |
| 提取企业发展基金 | 0 | 0 | 0 | 0 | 0 |
| 七、可供股东分配的利润 | 0 | 0 | 0 | 0 | 0 |
| 应付优先股股利 | 0 | 0 | 0 | 0 | 0 |
| 提取任意盈余公积金 | 0 | 0 | 0 | 0 | 0 |
| 应付普通股股利 | 0 | 0 | 0 | 0 | 0 |
| 转作股本的普通股股利 | 0 | 0 | 0 | 0 | 0 |
| 八、未分配利润 | 0 | 0 | 0 | 0 | 0 |
| 鑫富药业(002019) 利润表 |
| 报告期 | 2007-03-31 | 2006-12-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 |
| 一、主营业务收入 | 134,911,923 | 346,404,621 | 257,313,582 | 172,864,523 | 95,388,309 |
| 折扣与折让 | 0 | 0 | 0 | 0 | 0 |
| 主营业务收入净额 | 134,911,923 | 346,404,621 | 257,313,582 | 172,864,523 | 95,388,309 |
| 主营业务成本 | 70,056,294 | 224,954,467 | 173,201,368 | 120,890,752 | 68,521,470 |
| 主营业务税金及附加 | 1,252,544 | 3,104,360 | 2,477,944 | 1,761,310 | 767,070 |
| 二、主营业务利润 | 63,603,084 | 118,345,795 | 81,634,270 | 50,212,461 | 26,099,768 |
| 其他业务利润 | 0 | 1,322,219 | 736,601 | 390,640 | 139,953 |
| 存货跌价损失 | 0 | 0 | 0 | 0 | 0 |
| 营业费用 | 14,273,166 | 53,790,605 | 29,831,428 | 19,265,390 | 9,890,665 |
| 管理费用 | 14,727,635 | 39,805,185 | 25,882,197 | 14,264,277 | 5,775,453 |
| 财务费用 | 5,211,850 | 12,502,525 | 7,721,028 | 5,036,149 | 2,220,935 |
| 三、营业利润 | 28,109,129 | 13,569,698 | 18,936,218 | 12,037,285 | 8,352,669 |
| 投资收益 | 0 | -6,202,037 | -5,222,483 | -3,464,448 | -2,209,663 |
| 补贴收入 | 0 | 390,000 | 140,000 | 140,000 | 40,000 |
| 营业外收入 | 1,410 | 56,907 | 26,776 | 1,248 | 477 |
| 营业外支出 | 685,376 | 1,303,307 | 840,881 | 508,682 | 196,265 |
| 以前年度损益调整 | 0 | 0 | 0 | 0 | 0 |
| 营业外收支净额 | -683,966 | -1,246,399 | -814,105 | -507,434 | -195,788 |
| 四、利润总额 | 27,425,162 | 6,511,262 | 13,039,629 | 8,205,403 | 5,987,217 |
| 所得税 | 9,378,701 | 4,566,499 | 4,603,748 | 2,592,731 | 1,946,739 |
| 财政返还 | 0 | 0 | 0 | 0 | 0 |
| 少数股东权益 | 0 | 7,933 | 15,564 | 15,564 | 15,564 |
| 购买日前净利润 | 0 | 0 | 0 | 0 | 0 |
| 未确认的投资损失 | 0 | 0 | 0 | 0 | 0 |
| 五、净利润 | 18,046,462 | 1,936,831 | 8,420,317 | 5,597,107 | 4,024,914 |
| 年初未分配利润 | 0 | 78,708,187 | 78,708,187 | 78,708,187 | 78,708,187 |
| 调整以前年度损益 | 0 | 0 | 0 | 0 | 0 |
| 盈余公积转入 | 0 | 0 | 0 | 0 | 0 |
| 住房周转金转入 | 0 | 0 | 0 | 0 | 0 |
| 其他转入 | 0 | 0 | 0 | 0 | 0 |
| 六、可分配利润 | 0 | 80,645,017 | 87,128,504 | 84,305,294 | 82,733,101 |
| 提取法定盈余公积 | 0 | 162,008 | 0 | 0 | 0 |
| 提取法定公益金 | 0 | 0 | 0 | 0 | 0 |
| 职工奖金福利 | 0 | 0 | 0 | 0 | 0 |
| 提取储备基金 | 0 | 0 | 0 | 0 | 0 |
| 提取企业发展基金 | 0 | 0 | 0 | 0 | 0 |
| 七、可供股东分配的利润 | 0 | 80,483,010 | 87,128,504 | 84,305,294 | 82,733,101 |
| 应付优先股股利 | 0 | 0 | 0 | 0 | 0 |
| 提取任意盈余公积金 | 0 | 0 | 0 | 0 | 0 |
| 应付普通股股利 | 0 | 10,237,500 | 10,237,500 | 10,237,500 | 0 |
| 转作股本的普通股股利 | 0 | 0 | 0 | 0 | 0 |
| 八、未分配利润 | 0 | 70,245,510 | 76,891,004 | 74,067,794 | 82,733,101 |
| 鑫富药业(002019) 利润表 |
| 报告期 | 2005-12-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-12-31 |
| 一、主营业务收入 | 269,314,416 | 207,105,281 | 134,010,851 | 58,012,334 | 245,057,646 |
| 折扣与折让 | 0 | 0 | 0 | 0 | 0 |
| 主营业务收入净额 | 269,314,416 | 207,105,281 | 134,010,851 | 58,012,334 | 245,057,646 |
| 主营业务成本 | 188,725,216 | 142,981,857 | 89,231,423 | 40,083,401 | 164,217,710 |
| 主营业务税金及附加 | 2,557,036 | 2,013,166 | 1,151,215 | 295,936 | 1,383,847 |
| 二、主营业务利润 | 78,032,164 | 62,110,258 | 43,628,213 | 17,632,996 | 79,456,089 |
| 其他业务利润 | 1,313,359 | 663,909 | 427,986 | 186,513 | 1,209,695 |
| 存货跌价损失 | 0 | 0 | 0 | 0 | 0 |
| 营业费用 | 13,219,009 | 10,076,136 | 6,205,000 | 2,566,880 | 9,576,676 |
| 管理费用 | 27,415,750 | 21,681,457 | 12,303,620 | 3,636,310 | 29,620,100 |
| 财务费用 | 7,260,313 | 4,368,173 | 2,166,267 | 892,697 | 1,548,179 |
| 三、营业利润 | 31,450,451 | 26,648,401 | 23,381,313 | 10,723,623 | 39,920,828 |
| 投资收益 | -5,298,647 | -1,814,066 | -49,577 | -24,788 | 0 |
| 补贴收入 | 440,000 | 270,000 | 90,000 | 90,000 | 912,358 |
| 营业外收入 | 87,814 | 57,046 | 1,934 | 1,934 | 269,813 |
| 营业外支出 | 1,028,507 | 659,095 | 548,655 | 320,745 | 1,584,433 |
| 以前年度损益调整 | 0 | 0 | 0 | 0 | 0 |
| 营业外收支净额 | -940,694 | -602,049 | -546,721 | -318,810 | -1,314,620 |
| 四、利润总额 | 25,651,111 | 24,502,285 | 22,875,015 | 10,470,024 | 39,518,566 |
| 所得税 | 5,139,846 | 8,109,050 | 7,712,231 | 3,425,408 | 7,002,674 |
| 财政返还 | 0 | 0 | 0 | 0 | 0 |
| 少数股东权益 | 30,292 | 26,778 | 0 | 0 | 0 |
| 购买日前净利润 | 0 | 0 | 0 | 0 | 0 |
| 未确认的投资损失 | 0 | 0 | 0 | 0 | 0 |
| 五、净利润 | 20,480,973 | 16,366,456 | 15,162,783 | 7,044,616 | 32,515,892 |
| 年初未分配利润 | 70,679,296 | 70,679,296 | 70,679,296 | 70,679,296 | 43,040,787 |
| 调整以前年度损益 | 0 | 0 | 0 | 0 | 0 |
| 盈余公积转入 | 0 | 0 | 0 | 0 | 0 |
| 住房周转金转入 | 0 | 0 | 0 | 0 | 0 |
| 其他转入 | 0 | 0 | 0 | 0 | 0 |
| 六、可分配利润 | 91,160,269 | 87,045,752 | 85,842,079 | 77,723,912 | 75,556,679 |
| 提取法定盈余公积 | 1,952,082 | 0 | 0 | 0 | 3,251,589 |
| 提取法定公益金 | 0 | 0 | 0 | 0 | 1,625,795 |
| 职工奖金福利 | 0 | 0 | 0 | 0 | 0 |
| 提取储备基金 | 0 | 0 | 0 | 0 | 0 |
| 提取企业发展基金 | 0 | 0 | 0 | 0 | 0 |
| 七、可供股东分配的利润 | 89,208,187 | 87,045,752 | 85,842,079 | 77,723,912 | 70,679,296 |
| 应付优先股股利 | 0 | 0 | 0 | 0 | 0 |
| 提取任意盈余公积金 | 0 | 0 | 0 | 0 | 0 |
| 应付普通股股利 | 10,500,000 | 10,500,000 | 10,500,000 | 10,500,000 | 0 |
| 转作股本的普通股股利 | 0 | 0 | 0 | 0 | 0 |
| 八、未分配利润 | 78,708,187 | 76,545,752 | 75,342,079 | 67,223,912 | 70,679,296 |
| 鑫富药业(002019) 利润表 |
| 报告期 | 2004-09-30 | 2004-06-30 | 2003-12-31 | 2002-12-31 | 2001-12-31 |
| 一、主营业务收入 | 176,801,491 | 113,521,758 | 176,767,037 | 130,946,998 | 91,335,360 |
| 折扣与折让 | 0 | 0 | 0 | 0 | 0 |
| 主营业务收入净额 | 176,801,491 | 113,521,758 | 176,767,037 | 130,946,998 | 91,335,360 |
| 主营业务成本 | 110,572,583 | 68,319,177 | 121,146,186 | 87,711,714 | 54,820,499 |
| 主营业务税金及附加 | 983,002 | 676,168 | 911,540 | 658,672 | 435,525 |
| 二、主营业务利润 | 65,245,905 | 44,526,413 | 54,709,312 | 42,576,611 | 36,079,336 |
| 其他业务利润 | 714,697 | 480,920 | 654,889 | 292,233 | 389,546 |
| 存货跌价损失 | 0 | 0 | 0 | 0 | 0 |
| 营业费用 | 6,753,030 | 4,125,172 | 6,071,002 | 3,562,874 | 3,090,819 |
| 管理费用 | 23,182,175 | 10,041,558 | 16,301,028 | 12,392,271 | 6,241,503 |
| 财务费用 | 2,620,565 | 1,976,788 | 3,492,528 | 1,934,234 | 1,465,236 |
| 三、营业利润 | 33,404,833 | 28,863,814 | 29,499,643 | 24,979,466 | 25,671,324 |
| 投资收益 | 0 | 0 | 0 | 0 | 0 |
| 补贴收入 | 1,047,888 | 1,001,326 | 730,314 | 5,377,714 | 0 |
| 营业外收入 | 95,921 | 95,921 | 2,032,905 | 69,143 | 0 |
| 营业外支出 | 1,067,996 | 620,304 | 387,240 | 557,734 | 344,929 |
| 以前年度损益调整 | 0 | 0 | 0 | 0 | 0 |
| 营业外收支净额 | -972,076 | -524,383 | 1,645,666 | -488,591 | -344,929 |
| 四、利润总额 | 33,480,645 | 29,340,757 | 31,875,622 | 29,868,589 | 25,326,395 |
| 所得税 | 11,959,868 | 10,708,059 | 5,997,956 | 3,802,037 | 604,976 |
| 财政返还 | 0 | 0 | 0 | 0 | 0 |
| 少数股东权益 | 0 | 0 | 0 | 0 | 0 |
| 购买日前净利润 | 0 | 0 | 0 | 0 | 0 |
| 未确认的投资损失 | 0 | 0 | 0 | 0 | 0 |
| 五、净利润 | 21,520,777 | 18,632,698 | 25,877,666 | 26,066,552 | 24,721,419 |
| 年初未分配利润 | 43,040,787 | 43,040,787 | 32,294,771 | 25,738,202 | 4,724,996 |
| 调整以前年度损益 | 0 | 0 | 0 | 0 | 0 |
| 盈余公积转入 | 0 | 0 | 0 | 0 | 0 |
| 住房周转金转入 | 0 | 0 | 0 | 0 | 0 |
| 其他转入 | 0 | 0 | 0 | 0 | 0 |
| 六、可分配利润 | 64,561,564 | 61,673,485 | 58,172,437 | 51,804,754 | 29,446,415 |
| 提取法定盈余公积 | 0 | 0 | 2,587,767 | 2,606,655 | 2,472,142 |
| 提取法定公益金 | 0 | 0 | 1,293,883 | 1,303,328 | 1,236,071 |
| 职工奖金福利 | 0 | 0 | 0 | 0 | 0 |
| 提取储备基金 | 0 | 0 | 0 | 0 | 0 |
| 提取企业发展基金 | 0 | 0 | 0 | 0 | 0 |
| 七、可供股东分配的利润 | 64,561,564 | 61,673,485 | 54,290,787 | 47,894,771 | 25,738,202 |
| 应付优先股股利 | 0 | 0 | 0 | 0 | 0 |
| 提取任意盈余公积金 | 0 | 0 | 0 | 0 | 0 |
| 应付普通股股利 | 0 | 0 | 11,250,000 | 0 | 0 |
| 转作股本的普通股股利 | 0 | 0 | 0 | 15,600,000 | 0 |
| 八、未分配利润 | 64,561,564 | 61,673,485 | 43,040,787 | 32,294,771 | 25,738,202 |